Skip to Content

RxSight Inc RXST

Morningstar Rating
$58.08 +0.56 (0.97%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RXST is trading at a 162% premium.
Price
$57.45
Fair Value
$88.74
Uncertainty
Very High
1-Star Price
$818.22
5-Star Price
$86.77
Economic Moat
Nlg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RXST is a good fit for your portfolio.

Trading Information

Previous Close Price
$57.52
Day Range
$57.7760.05
52-Week Range
$20.6666.54
Bid/Ask
$58.10 / $61.68
Market Cap
$2.28 Bil
Volume/Avg
395,417 / 400,882

Key Statistics

Price/Earnings (Normalized)
Price/Sales
20.34
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
374

Comparables

Valuation

Metric
RXST
STAA
EMBC
Price/Earnings (Normalized)
43.793.73
Price/Book Value
13.044.81
Price/Sales
20.345.840.66
Price/Cash Flow
37.286.70
Price/Earnings
RXST
STAA
EMBC

Financial Strength

Metric
RXST
STAA
EMBC
Quick Ratio
8.024.991.55
Current Ratio
9.205.842.20
Interest Coverage
−27.341.59
Quick Ratio
RXST
STAA
EMBC

Profitability

Metric
RXST
STAA
EMBC
Return on Assets (Normalized)
−13.53%7.37%12.15%
Return on Equity (Normalized)
−16.23%9.21%
Return on Invested Capital (Normalized)
−17.05%7.12%28.15%
Return on Assets
RXST
STAA
EMBC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
CrnnbrlbZhpvtz$181.6 Bil
Stryker Corp
SYK
NfcbzqybSzcv$132.0 Bil
Boston Scientific Corp
BSX
VpfhqxhjRnrpdb$113.4 Bil
Medtronic PLC
MDT
KgsxsrztGxgnctk$107.5 Bil
Edwards Lifesciences Corp
EW
HlcfpjrrkcRgbzgfw$51.9 Bil
DexCom Inc
DXCM
NwttpwgqzCyppb$46.2 Bil
Koninklijke Philips NV ADR
PHG
YhdqgqyrbYyfhql$24.7 Bil
Zimmer Biomet Holdings Inc
ZBH
MjdmtfdkGftv$22.5 Bil
Steris PLC
STE
XjjgcjpKsbshry$22.3 Bil
Align Technology Inc
ALGN
JnkrrbvbFtjtffx$20.0 Bil

Sponsor Center